Introducing the Metabolon eBook:


Using Precision Metabolomics™
to Evaluate a Drug’s Ability to Deliver
the Target Product Profile

Obtaining the data and biomarkers needed to drive decisions

Estimates vary, but the time and cost of bringing a drug successfully to market is over 12 years and greater than a billion dollars. These staggering estimates are driven by a >95% failure rate.

Most assessments of these high failure rates contend that, although the ultimate failure occurs in the clinic, that “clinical” failure is a more holistic problem that starts at discovery and extends all the way to the clinic. This eBook will focus on using metabolomics throughout the R&D process as an ally to improve the clinical success rate, and by producing a comprehensive and meaningful assessment of the molecular phenotype one can enrich the biomarker and information armament to inform decisions across this continuum.